Department of Radiology
Found 6 results
Filters: Author is Aarsland, Dag  [Clear All Filters]
2022
Jansen WJ, Janssen O, Tijms BM, Vos SJB, Ossenkoppele R, Visser PJelle, Aarsland D, Alcolea D, Altomare D, von Arnim C et al..  2022.  Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.. JAMA Neurol. 79(3):228-243.
2018
Jansen WJ, Ossenkoppele R, Tijms BM, Fagan AM, Hansson O, Klunk WE, van der Flier WM, Villemagne VL, Frisoni GB, Fleisher AS et al..  2018.  Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia.. JAMA Psychiatry. 75(1):84-95.
Mattsson N, Groot C, Jansen WJ, Landau SM, Villemagne VL, Engelborghs S, Mintun MM, Lleó A, Molinuevo JLuis, Jagust WJ et al..  2018.  Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease.. Alzheimers Dement. 14(7):913-924.
2015
Jansen WJ, Ossenkoppele R, Knol DL, Tijms BM, Scheltens P, Verhey FRJ, Visser PJelle, Aalten P, Aarsland D, Alcolea D et al..  2015.  Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.. JAMA. 313(19):1924-38.
2014
Duits FH, Teunissen CE, Bouwman FH, Visser P-J, Mattsson N, Zetterberg H, Blennow K, Hansson O, Minthon L, Andreasen N et al..  2014.  The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean? Alzheimers Dement. 10(6):713-723.e2.
2009
Mattsson N, Zetterberg H, Hansson O, Andreasen N, Parnetti L, Jonsson M, Herukka S-K, van der Flier WM, Blankenstein MA, Ewers M et al..  2009.  CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.. JAMA. 302(4):385-93.